LEF1 IHC has been recently introduced as a useful tool in the diagnosis of solid-pseudopapillary neoplasm of the pancreas, a tumour with a gain-of-function mutation in CTNNB1 [31]. Here, CTNNB1 is linked to Solid Pseudopapillary Neoplasm of the Pancreas.